Litecoin gets its first major treasury backer in MEI Pharma’s $100m play

MEI Pharma, a clinical-stage biotech firm, just made an unexpected pivot, allocating nine figures to Litecoin as a treasury asset. With GSR advising and Charlie Lee on board, the move signals a growing institutional belief in crypto’s role beyond speculation.…